| 炎症性肠病治疗方法研究进展 |
| |
| 引用本文： | 郭静,王立云. 炎症性肠病治疗方法研究进展[J]. 国际儿科学杂志, 2016, 0(5): 377-381. DOI: 10.3760/cma.j.issn.1673-4408.2016.05.008 |
| |
| 作者姓名： | 郭静 王立云 |
| |
| 作者单位： | 中国医科大学附属盛京医院儿科,沈阳,110004 |
| |
| 基金项目： | The National Natural Science Foundation of China Youth Foundation(81400585)，Liaoning Province Natural Science Foundation(2014021042)，National Clinical Key Specialty Construction Projects，国家自然科学基金青年基金(81400585)，辽宁省自然科学基金(2014021042)，国家临床重点专科建设项目 |
| |
| 摘 要： | 炎症性肠病是肠道慢性非特异性炎症,其病因和发病机制尚不十分清楚.目前常规治疗包括水杨酸类药物、激素、免疫抑制剂、生物制剂及手术等,但预后仍不乐观.近年来,多种其他治疗方案不断出现,如抗细胞因子抗体、抗趋化因子抗体等,使临床医生越来越关注炎症性肠病新的治疗方法.
|
| 关 键 词： | 炎症性肠病 细胞因子 趋化因子 治疗 |
Advances in the treatment of inflammatory bowel disease |
| |
| Abstract: | Inflammatory bowel disease is a chronic non-specific intestinal tract inflammation,currently,its etiology and pathogenesis are not clear.The current conventional treatments include salicylic acid drugs, steroids, immunosuppressive agents, biological agents and surgery, but the prognosis is still not very optimistic.In recent years, a variety of other treatment options have emerged, such as anti-cytokine antibody, anti-chemokine antibodies.Clinicians pay more attention to treatment of inflammatory bowel disease. |
| |
| Keywords: | Inflammatory bowel disease Cytokine Chemokine Treatment |
| 本文献已被 万方数据 等数据库收录！ |
|
